ストックスクリーナーアプリを入手
23.29
1.97%
0.45
アフターアワーズ：
22.82
-0.47
-2.02%
前日終値:
$22.84
開ける：
$22.85
24時間の取引高:
495.41K
Relative Volume:
0.37
時価総額：
$1.73B
収益：
$314.00K
当期純損益:
$-237.73M
株価収益率:
-4.7823
EPS:
-4.87
ネットキャッシュフロー:
$-185.07M
1週間 パフォーマンス:
+2.42%
1か月 パフォーマンス:
-2.63%
6か月 パフォーマンス:
+51.23%
1年 パフォーマンス:
+53.32%
1日の値動き範囲:
$22.31
$23.34
1週間の範囲:
$21.53
$23.34
52週間の値動き範囲:
$11.40
$25.39
Viridian Therapeutics Inc Stock (VRDN) Company Profile
Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-06-14 | 開始されました | BTIG Research | Buy |
| 2023-06-14 | 再開されました | Credit Suisse | Outperform |
| 2023-05-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-04-17 | 開始されました | Wells Fargo | Overweight |
| 2023-03-30 | 開始されました | Stifel | Buy |
| 2022-12-19 | 開始されました | Cowen | Outperform |
| 2022-12-19 | 開始されました | Needham | Buy |
| 2022-12-16 | 開始されました | Credit Suisse | Outperform |
| 2022-12-01 | 開始されました | H.C. Wainwright | Buy |
| 2022-06-23 | 開始されました | B. Riley Securities | Buy |
| 2021-11-18 | 開始されました | SVB Leerink | Outperform |
| 2021-10-12 | 開始されました | Evercore ISI | Outperform |
| 2021-01-25 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Viridian Therapeutics Inc (VRDN) 最新ニュース
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
(VRDN) Long Term Investment Analysis - Stock Traders Daily
Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings - Yahoo Finance
Analyst Expectations For Viridian Therapeutics's Future - Fidelity Investments
Needham & Company LLC Reaffirms Buy Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Position Boosted by Novo Holdings A S - MarketBeat
How To Trade (VRDN) - Stock Traders Daily
VRDN Factor-Based Stock Analysis - Nasdaq
Viridian Therapeutics' Superior Prospects Make It A Buy (NASDAQ:VRDN) - Seeking Alpha
Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical Results - Insider Monkey
8 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
SG Americas Securities LLC Has $374,000 Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
State Street Corp's Strategic Reduction in Viridian Therapeutics Inc - Yahoo Finance
Viridian Therapeutics (NASDAQ:VRDN) Hits New 52-Week HighTime to Buy? - MarketBeat
Viridian Therapeutics Inc (VRDN) stock analysis: A comprehensive overview - US Post News
Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Acquired by Millennium Management LLC - MarketBeat
Financial Snapshot: Analyzing Viridian Therapeutics Inc (VRDN)’s Key Ratio Metrics - The Dwinnex
Dimensional Fund Advisors LP Purchases 97,510 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
Viridian Therapeutics Inc [VRDN] Records 50-Day SMA of $18.29 - Knox Daily
Viridian Therapeutics (NASDAQ:VRDN) Stock Price Up 6.4%Should You Buy? - MarketBeat
Viridian Therapeutics Inc (VRDN) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
The growth track for Viridian Therapeutics Inc (VRDN) has changed recently - SETE News
Stock Performance Spotlight: Viridian Therapeutics Inc (VRDN) Ends the Day at 23.40, Up by 0.60 - The Dwinnex
Viridian Therapeutics Inc (VRDN) receives a Buy rating from Needham - Knox Daily
A stock that deserves closer examination: Viridian Therapeutics Inc (VRDN) - US Post News
(VRDN) Trading Signals - Stock Traders Daily
Insider Purchase: President and CEO Stephen Mahoney Acquires Sha - GuruFocus.com
Viridian Therapeutics (NASDAQ:VRDN) Sets New 52-Week High After Insider Buying Activity - MarketBeat
Viridian Therapeutics CEO buys $499k worth of company stock By Investing.com - Investing.com South Africa
Insider Buying: COO Thomas Beetham Acquires Shares of Viridian T - GuruFocus.com
Viridian Therapeutics' SWOT analysis: biotech stock poised for growth in TED market By Investing.com - Investing.com South Africa
Viridian Therapeutics' SWOT analysis: biotech stock poised for growth in TED market - Investing.com Australia
Viridian Therapeutics COO buys $117k in company stock By Investing.com - Investing.com South Africa
Viridian Therapeutics COO buys $117k in company stock - Investing.com
Viridian Therapeutics CEO buys $499k worth of company stock - Investing.com
Novo Holdings A S Grows Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
Short Interest in Viridian Therapeutics, Inc. (NASDAQ:VRDN) Increases By 30.3% - MarketBeat
Maverick Capital Ltd. Buys 615,531 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
Viridian’s Veligrotug Poses Formidable Challenge For Amgen’s Tepezza In TED - Scrip
Forecasting The Future: 13 Analyst Projections For Viridian Therapeutics - Benzinga
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $35.30 Average PT from Brokerages - MarketBeat
Viridian Therapeutics (NASDAQ:VRDN) Trading Up 2.3% - MarketBeat
Affinity Asset Advisors LLC Invests $1.95 Million in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
Great Point Partners LLC Sells 835,000 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
Viridian Therapeutics (NASDAQ:VRDN) Trading Down 4.9% - MarketBeat
Stock Surge: Viridian Therapeutics Inc (VRDN) Closes at 22.30, Marking a -0.89 Increase/Decrease - The Dwinnex
Viridian (VRDN): A Biotech Targeting Rare Disease Growth - Value the Markets
Rhumbline Advisers Purchases 23,305 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat
Trading (VRDN) With Integrated Risk Controls - Stock Traders Daily
Viridian Therapeutics Inc (VRDN) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):